DeepMed Research

UNIVERSITY COLLEGE LONDON

🇬🇧United Kingdom

Country: 🇬🇧United Kingdom

Ownership: Private

Established: 1826-02-11

Employees: 10K

Market Cap: -

Website: http://www.ucl.ac.uk

Clinical Trials

1 Year Post Discharge Prognostic Model From the National Heart Failure Audit (NHFA)

Conditions: Heart Failure

Interventions: Other: Heart Failure Management

First Posted Date: 2015-02-02

Last Posted Date: 2015-02-03

Lead Sponsor: University College, London

Target Recruit Count: 63320

Registration Number: NCT02353481

Locations: 🇬🇧
University College London, London, United Kingdom

Trial of Sertraline Versus Cognitive Behaviour Therapy for Generalised Anxiety

Phase 4

Terminated

Conditions: Generalised Anxiety Disorder

Interventions: Behavioral: Cognitive Behavioural Therapy
Drug: Sertraline

First Posted Date: 2015-01-27

Last Posted Date: 2016-07-11

Lead Sponsor: University College, London

Target Recruit Count: 5

Registration Number: NCT02347033

Locations: 🇬🇧
Camden & Islington (with Kingston), London, United Kingdom

A Phase II Multicentre Trial of Endoscopic Ultrasound Guided Radiofrequency Ablation of Cystic Tumours of the Pancreas

Not Applicable

Conditions: Pancreatic Cyst

Interventions: Procedure: EUS guided RFA of cystic tumours of the pancreas

First Posted Date: 2015-01-22

Last Posted Date: 2019-10-02

Lead Sponsor: University College, London

Target Recruit Count: 97

Registration Number: NCT02343692

Locations: 🇦🇺
Royal Melbourne Hospital, Epworth Richmond, Melbourne, Australia
🇬🇧
Homerton University Hospital NHS Foundation Trust, London, United Kingdom
🇬🇧
University Hospital Birmingham NHS FoundationTrust, Birmingham, United Kingdom

and more 10 locations

Effect of Remote Ischaemic Conditioning on Clinical Outcomes in STEMI Patients Undergoing PPCI (CONDI2/ERIC-PPCI)

Not Applicable

Completed

Conditions: STEMI
Myocardial Reperfusion Injury

Interventions: Device: Control
Device: Remote ischemic conditioning

First Posted Date: 2015-01-21

Last Posted Date: 2019-08-29

Lead Sponsor: University College, London

Target Recruit Count: 5413

Registration Number: NCT02342522

Locations: 🇪🇸
Hospital Universitario Central de Asturias, Oviedo, Asturias, Spain
🇷🇸
Clinical Centre of Serbia, Belgrade, Serbia
🇩🇰
Aalborg University Hospital, Aalborg, Denmark

and more 32 locations

PICTURE Breast L: Patient Information Combined for Local Therapy oUtcome Assessment in bREast Cancer - Longitudinal

Completed

Conditions: Breast Neoplasms

First Posted Date: 2015-01-19

Last Posted Date: 2017-03-17

Lead Sponsor: University College, London

Target Recruit Count: 83

Registration Number: NCT02341820

Locations: 🇬🇧
Royal Free Hospital, London, United Kingdom
🇳🇱
Leiden University Medical Center (LUMC), Leiden, Netherlands
🇵🇹
Champalimaud Cancer Center, Lisbon, Portugal

SmartTarget: BIOPSY

Not Applicable

Completed

Conditions: Prostatic Neoplasms
Diagnostic Techniques and Procedures

Interventions: Procedure: SmartTarget - Biopsy

First Posted Date: 2015-01-19

Last Posted Date: 2019-01-31

Lead Sponsor: University College, London

Target Recruit Count: 134

Registration Number: NCT02341677

Locations: 🇬🇧
University College London, London, United Kingdom

Care for Late Stage Parkinsonism

Not Applicable

Completed

Conditions: Late Stage Parkinson's Disease
Parkinson's Disease

Interventions: Other: Specialist review

First Posted Date: 2015-01-07

Last Posted Date: 2021-04-28

Lead Sponsor: University College, London

Target Recruit Count: 184

Registration Number: NCT02333175

Locations: 🇵🇹
Instituto de Medicina Molecular, Lisbon, Portugal
🇩🇪
University of Munich, Munich, Bavaria, Germany
🇫🇷
University of Bordeaux, Bordeaux, France

and more 4 locations

Carfilzomib/Cyclophosphamide/Dexamethasone with Maintenance Carfilzomib in Multiple Myeloma

Phase 2

Active, not recruiting

Conditions: Multiple Myeloma

Interventions: Drug: Consolidation with 4 cycles of CarCyDex
Procedure: Autologous Stem Cell Transplant (ASCT)

First Posted Date: 2014-12-12

Last Posted Date: 2024-12-06

Lead Sponsor: University College, London

Target Recruit Count: 281

Registration Number: NCT02315716

Locations: 🇬🇧
Queen's Hospital, Romford, Essex, United Kingdom
🇬🇧
Royal United Hospital, Bath, United Kingdom
🇬🇧
Maidstone and Tunbridge Wells, Maidstone, United Kingdom

and more 17 locations

Deciphering Antitumour Response and Resistance With INtratumour Heterogeneity

Phase 2

Active, not recruiting

Conditions: Non-small Cell Lung Cancer

Interventions: Drug: Vemurafenib
Drug: Alectinib
Drug: Trastuzumab emtansine

First Posted Date: 2014-12-11

Last Posted Date: 2025-05-23

Lead Sponsor: University College, London

Target Recruit Count: 50

Registration Number: NCT02314481

Locations: 🇬🇧
Univeristy College London Hospital, London, United Kingdom

Myloablative Cord Blood Transplant in Haematological Malignancies (MAC UCBT)

Phase 2

Terminated

Conditions: Leukaemia
Other Haematological Diseases
Lymphoma

Interventions: Other: Umbilical Cord Blood Transplant
Drug: Cyclophosphamide
Radiation: Total body irradiation
Drug: Busulfan
Drug: Fludarabine
Drug: Melphalan

First Posted Date: 2014-12-08

Last Posted Date: 2015-05-27

Lead Sponsor: University College, London

Target Recruit Count: 11

Registration Number: NCT02310997

Locations: 🇬🇧
Nottingham City Hospital, Nottingham, United Kingdom
🇬🇧
Bristol Haematology & Oncology Centre, Bristol, United Kingdom
🇬🇧
University College London Hospital, London, Greater London, United Kingdom

and more 9 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy